Strategies for developing biomarkers of heart failure
SA Jortani, SD Prabhu, R Valdes Jr - Clinical chemistry, 2004 - academic.oup.com
Background: Heart failure (HF) is a devastating disease with increasing prevalence in
elderly populations. One-half of all patients die within 5 years of diagnosis. The annual cost …
elderly populations. One-half of all patients die within 5 years of diagnosis. The annual cost …
[引用][C] Strategies for developing Biomarkers of heart failure
SA JORTANI, SD PRABHU… - Clinical chemistry …, 2004 - pascal-francis.inist.fr
Strategies for developing Biomarkers of heart failure CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Strategies for Developing Biomarkers of Heart Failure
SA Jortani, SD Prabhu, R Valdes Jr - Clinical Chemistry, 2004 - search.proquest.com
Heart failure (HF) is a devastating disease with increasing prevalence in elderly populations.
One-half of all patients die within 5 years of diagnosis. The annual cost of treating patients …
One-half of all patients die within 5 years of diagnosis. The annual cost of treating patients …
[PDF][PDF] Strategies for Developing Biomarkers of Heart Failure
SA Jortani, SD Prabhu, R Valdes Jr - academia.edu
Background: Heart failure (HF) is a devastating disease with increasing prevalence in
elderly populations. Onehalf of all patients die within 5 years of diagnosis. The annual cost …
elderly populations. Onehalf of all patients die within 5 years of diagnosis. The annual cost …
[引用][C] Strategies for developing biomarkers of heart failure
SA Jortani, SD Prabhu, R Valdes Jr - Clinical Chemistry, 2004 - go.gale.com
Strategies for developing biomarkers of heart failure
SA Jortani, SD Prabhu, R Valdes Jr - Clinical chemistry, 2004 - pubmed.ncbi.nlm.nih.gov
Background Heart failure (HF) is a devastating disease with increasing prevalence in elderly
populations. One-half of all patients die within 5 years of diagnosis. The annual cost of …
populations. One-half of all patients die within 5 years of diagnosis. The annual cost of …
[PDF][PDF] Strategies for Developing Biomarkers of Heart Failure
SA Jortani, SD Prabhu, R Valdes Jr - 2004 - researchgate.net
Background: Heart failure (HF) is a devastating disease with increasing prevalence in
elderly populations. Onehalf of all patients die within 5 years of diagnosis. The annual cost …
elderly populations. Onehalf of all patients die within 5 years of diagnosis. The annual cost …
Strategies for Developing Biomarkers of Heart Failure
SA Jortani, SD Prabhu, R Valdes - Clinical chemistry, 2004 - profiles.wustl.edu
Background: Heart failure (HF) is a devastating disease with increasing prevalence in
elderly populations. One-half of all patients die within 5 years of diagnosis. The annual cost …
elderly populations. One-half of all patients die within 5 years of diagnosis. The annual cost …
Strategies for developing biomarkers of heart failure.
SA Jortani, SD Prabhu, R Valdes Jr - Clinical Chemistry, 2003 - europepmc.org
Background Heart failure (HF) is a devastating disease with increasing prevalence in elderly
populations. One-half of all patients die within 5 years of diagnosis. The annual cost of …
populations. One-half of all patients die within 5 years of diagnosis. The annual cost of …